UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optoelectronic sampling of ultrafast electric transients with single quantum dots

Applied physics letters, 2021-11, Vol.119 (18)

2021

Volltextzugriff (PDF)

Ultrafast electric phase control of a single exciton qubit

Applied physics letters, 2018-03, Vol.112 (11)

2018

Volltextzugriff (PDF)

Electrically controlled rapid adiabatic passage in a single quantum dot

Applied physics letters, 2020-06, Vol.116 (25)

2020

Volltextzugriff (PDF)

Mathematical Modelling Of The Molecular BCR-ABL1 Transcript Response In Chronic Myeloid Leukemia: A Comparison Of Adult and Pediatric Patients

Blood, 2013-11, Vol.122 (21), p.2709-2709

2013

Volltextzugriff (PDF)

The Challenge of Postoperative Infections: Does the Surgeon Make a Difference?

Infection control and hospital epidemiology, 1997-06, Vol.18 (6), p.449-456

1997

Volltextzugriff (PDF)

The challenge of postoperative infections: does the surgeon make a difference?

Infection control and hospital epidemiology, 1997-06, Vol.18 (6), p.449-456

1997

Volltextzugriff (PDF)

Abstract 692: Pappalysin-1 is a suitable target for T cell receptor transgenic T cells to kill Ewing sarcoma in vivo and in vitro

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.692-692

2017

Volltextzugriff (PDF)

Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics

Blood, 2022-11, Vol.140 (Supplement 1), p.4011-4012

2022

Volltextzugriff (PDF)

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Blood, 2023-11, Vol.142 (Supplement 1), p.721-721

2023

Volltextzugriff (PDF)

Mimicking Clinical Trials with Synthetic Acute Myeloid Leukemia Patients Using Generative Artificial Intelligence

Blood, 2023-11, Vol.142 (Supplement 1), p.2268-2268

2023

Volltextzugriff (PDF)

Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial

Blood, 2018-11, Vol.132 (Supplement 1), p.661-661

2018

Volltextzugriff (PDF)

Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.523-525

2022

Volltextzugriff (PDF)

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.13-13

2019

Volltextzugriff (PDF)

Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.1-3

2020

Volltextzugriff (PDF)

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

Blood, 2018-11, Vol.132 (Supplement 1), p.3902-3902

2018

Volltextzugriff (PDF)

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Blood, 2021-11, Vol.138 (Supplement 1), p.1307-1307

2021

Volltextzugriff (PDF)

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.1461-1461

2018

Volltextzugriff (PDF)

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Blood, 2017-12, Vol.130 (Suppl_1), p.721-721

2017

Volltextzugriff (PDF)

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Blood, 1998-01, Vol.91 (1), p.22-29

1998

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieProcedia Cirp

SprachePortugiesisch

ThemaCenozoic

ThemaLife Sciences & Biomedicine

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optoelectronic sampling of ultrafast electric transients with single quantum dots

Ultrafast electric phase control of a single exciton qubit

Electrically controlled rapid adiabatic passage in a single quantum dot

Mathematical Modelling Of The Molecular BCR-ABL1 Transcript Response In Chronic Myeloid Leukemia: A Comparison Of Adult and Pediatric Patients

The Challenge of Postoperative Infections: Does the Surgeon Make a Difference?

The challenge of postoperative infections: does the surgeon make a difference?

Abstract 692: Pappalysin-1 is a suitable target for T cell receptor transgenic T cells to kill Ewing sarcoma in vivo and in vitro

BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

Activation of Distinct Inflammatory Pathways in LR-MDS Is Determined By Genetics

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Mimicking Clinical Trials with Synthetic Acute Myeloid Leukemia Patients Using Generative Artificial Intelligence

Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome

Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial

Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial

Impact of KMT2A -PTD Mutational Subgroups on Outcome of AML Patients after Induction Therapy and Allogeneic Hematopoietic Cell Transplantation

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia

Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Response to Front-Line Imatinib Treatment in Children and Adolescents with CML - Data from a Large Pediatric Cohort

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Aktive Filter

Suchergebnisse filtern